Trilogy Capital’s Xtrackers USD High Yield Corporate Bond ETF HYLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-120,386
Closed -$4.54M 168
2022
Q1
$4.54M Sell
120,386
-140,662
-54% -$5.39M 0.33% 51
2021
Q4
$10.4M Buy
261,048
+105,153
+67% +$4.18M 0.78% 39
2021
Q3
$6.25M Buy
155,895
+8,013
+5% +$322K 0.48% 43
2021
Q2
$5.96M Buy
147,882
+23,404
+19% +$937K 0.44% 44
2021
Q1
$4.98M Buy
124,478
+25,847
+26% +$1.03M 0.38% 52
2020
Q4
$3.95M Buy
98,631
+10,133
+11% +$398K 0.32% 52
2020
Q3
$3.4M Buy
88,498
+10,234
+13% +$395K 0.33% 54
2020
Q2
$3.01M Buy
78,264
+3,223
+4% +$119K 0.3% 57
2020
Q1
$2.7M Sell
75,041
-3,108
-4% -$120K 0.3% 54
2019
Q4
$3.15M Sell
78,149
-4,910
-6% -$196K 0.31% 54
2019
Q3
$3.3M Sell
83,059
-4,766
-5% -$191K 0.35% 54
2019
Q2
$3.52M Buy
+87,825
New +$3.49M 0.39% 51

Other funds holding HYLB

Trilogy Capital's HYLB Position: Q2 2022 in Review

Trilogy Capital sold out of Xtrackers USD High Yield Corporate Bond ETF (HYLB) in Q2 2022, closing a stake of 120,386 shares — an estimated $4.54M sold.

Trilogy Capital first reported a position in HYLB in Q2 2019 and held it in 12 quarters. The position peaked at $10.4M in Q4 2021. 212 funds tracked by Wall St. Rank hold HYLB as of Q2 2022.

  • Trilogy Capital reported no remaining Xtrackers USD High Yield Corporate Bond ETF position as of Q2 2022 after selling out during the quarter.
  • Trilogy Capital sold 120,386 Xtrackers USD High Yield Corporate Bond ETF shares in Q2 2022, an estimated $4.54M.
  • Trilogy Capital first reported a position in Xtrackers USD High Yield Corporate Bond ETF in Q2 2019 and held it in 12 quarters.
  • Trilogy Capital's Xtrackers USD High Yield Corporate Bond ETF position peaked at $10.4M in Q4 2021.
  • 212 funds tracked by Wall St. Rank held Xtrackers USD High Yield Corporate Bond ETF as of Q2 2022.

Based on Trilogy Capital's 13F filing for Q2 2022, filed 20 Jul 2022.